Target intelligence / Profile preview

Phospholipase A2 (PLA2)

Target
PLA2
Molecular classification
Enzyme, Hydrolase, Esterase
01

Overview

Phospholipase A2 (PLA2) refers to a superfamily of enzymes that hydrolyze the ester bond at the sn-2 position of phospholipids, releasing a free fatty acid and a lysophospholipid. This reaction is crucial in lipid metabolism and cell signaling, particularly in generating arachidonic acid for eicosanoid biosynthesis, which plays key roles in inflammation and other physiological processes. The PLA2 superfamily is diverse, comprising at least six major families based on structure, location, substrate specificity, and physiological role, including secreted PLA2 (sPLA2), cytosolic PLA2 (cPLA2), Ca²⁺-independent PLA2 (iPLA2), lipoprotein-associated PLA2 (LpPLA2), lysosomal PLA2 (LPLA2), and adipose-tissue-specific PLA2 (AdPLA). Elevated levels or altered activities serve as biomarkers or therapeutic targets for several conditions, and inhibitors targeting specific groups/isoforms are under investigation for anti-inflammatory therapies.

02

Mechanism of action

Inhibition of phospholipase A2 activity, blocking the release of arachidonic acid and subsequent production of inflammatory mediators.

03

Biological functions

Lipid metabolismCell signalingArachidonic acid releaseEicosanoid biosynthesisLipid digestionHost defense
04

Disease associations

Inflammatory diseases (rheumatoid arthritis, asthma)Cardiovascular diseaseNeurodegenerative disorders (Alzheimer’s disease, multiple sclerosis)Cancer progressionSepsisAcute respiratory distress syndromeOcular surface inflammation/dry eye
05

Safety considerations

Lack of inhibitor specificity due to interfacial catalysis mechanisms affecting inhibitor binding efficacy.Potential for off-target effects due to diverse isoforms and functions.
06

Interacting drugs

PLA2 inhibitors (specific groups/isoforms)
07

Biomarkers

Elevated PLA2 levelsAltered PLA2 activityLp-PLA2

Beyond the preview

Go deeper on Phospholipase A2 (PLA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipase A2 (PLA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call